Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that its partner, Roche, is designing a new Phase 2 trial to evaluate tominersen in Huntington's disease (HD)....
The Bay is pleased to announce the appointment of Alexander Meyer as Chief Customer Officer. Alexander will be responsible for the ongoing transformation of...
Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced the initiation of patient...
TheraVet (Paris:ALVET) (Brussels:ALVET) (ISIN: BE0974387194 - ticker: ALVET), a biotech company developing pioneering treatments for osteoarticular disease in pets, announced today the signature of...
Kosmos Energy (“Kosmos” or the “Company”) announced today completion of the drilling of the Winterfell-2 appraisal well on Block 943 in the Green Canyon...
